{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:40:37Z","timestamp":1777084837169,"version":"3.51.4"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T00:00:00Z","timestamp":1683936000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Journal"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.bj.2023.100607","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T02:45:08Z","timestamp":1684205108000},"page":"100607","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomes"],"prefix":"10.1016","volume":"47","author":[{"given":"Eugene Yu-Chuan","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shih-Chieh","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-Cheng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunir J.","family":"Garg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuan-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Chi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Chun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yih-Shiou","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.bj.2023.100607_bib1","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0039-6257(04)00109-2","article-title":"Macular edema","volume":"49","author":"Tranos","year":"2004","journal-title":"Surv Ophthalmol"},{"issue":"4","key":"10.1016\/j.bj.2023.100607_bib2","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1167\/iovs.04-0905","article-title":"Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina","volume":"46","author":"Tamura","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.bj.2023.100607_bib3","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/db07-0982","article-title":"Intravitreal triamcinolone acetonide inhibits breakdown of the blood-retinal barrier through differential regulation of VEGF-A and its receptors in early diabetic rat retinas","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.bj.2023.100607_bib4","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.ophtha.2010.03.032","article-title":"Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion","volume":"117","author":"Haller","year":"2010","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.bj.2023.100607_bib5","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archophthalmol.2010.339","article-title":"Dexamethasone intravitreal implant for noninfectious intermediate or posterior uveitis","volume":"129","author":"Lowder","year":"2011","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"10.1016\/j.bj.2023.100607_bib6","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1016\/j.ophtha.2014.04.024","article-title":"Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema","volume":"121","author":"Boyer","year":"2014","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.bj.2023.100607_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1001\/archophthalmol.2009.234","volume":"127","author":"Ip","year":"2009","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.bj.2023.100607_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/biom.13609","article-title":"Improving trial generalizability using observational studies","volume":"79","author":"Lee","year":"2023","journal-title":"Biometrics"},{"issue":"9","key":"10.1016\/j.bj.2023.100607_bib9","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/bcp.14024","article-title":"Pharmacoepidemiology: using randomised control trials and observational studies in clinical decision\u2010making","volume":"85","author":"Caparrotta","year":"2019","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.bj.2023.100607_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20949","article-title":"Differences between randomized clinical trial participants and real-world empagliflozin users and the changes in their glycated hemoglobin levels","volume":"3","author":"Munk","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000742","article-title":"Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients?","volume":"7","author":"Shao","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.bj.2023.100607_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0209997","article-title":"Hospital Cl\u00ednic\u2010\u2010Hospital Vall de Hebron Intravitreal Dexamethasone Implant study group. Long-term probability of intraocular pressure elevation with the intravitreal dexamethasone implant in the real-world","volume":"14","author":"Zarranz-Ventura","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.bj.2023.100607_bib13","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1111\/aos.14141","article-title":"Association of glaucoma with risk of retinal vein occlusion: a meta-analysis","volume":"97","author":"Yin","year":"2019","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.bj.2023.100607_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.4239\/wjd.v2.i6.98","article-title":"Managing diabetic macular edema: the leading cause of diabetes blindness","volume":"2","author":"Romero-Aroca","year":"2011","journal-title":"World J Diabetes"},{"issue":"5","key":"10.1016\/j.bj.2023.100607_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/pds.4713","article-title":"The Chang Gung Research Database\u2014a multi\u2010institutional electronic medical records database for real\u2010world epidemiological studies in Taiwan","volume":"28","author":"Shao","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"5","key":"10.1016\/j.bj.2023.100607_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.bj.2017.08.002","article-title":"Chang Gung Research Database: a multi-institutional database consisting of original medical records","volume":"40","author":"Tsai","year":"2017","journal-title":"Biomed J"},{"key":"10.1016\/j.bj.2023.100607_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/CLEP.S335517","article-title":"Positive predictive value of ICD-10 codes for cerebral venous sinus thrombosis in Taiwan\u2019s national Health insurance claims database","volume":"14","author":"Liao","year":"2022","journal-title":"Clin Epidemiol"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-019-0919-9","article-title":"Comparative risk evaluation for cardiovascular events associated with dapagliflozin vs. empagliflozin in real-world type 2 diabetes patients: a multi-institutional cohort study","volume":"18","author":"Shao","year":"2019","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.bj.2023.100607_bib19","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bj.2021.12.006","article-title":"Discharge status validation of the Chang Gung Research database in taiwan","volume":"45","author":"Huang","year":"2022","journal-title":"Biomed J"},{"issue":"8","key":"10.1016\/j.bj.2023.100607_bib20","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1001\/jama.2018.0246","article-title":"Association of varicose veins with incident venous thromboembolism and peripheral artery disease","volume":"319","author":"Chang","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.bj.2023.100607_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.882632","article-title":"Validation of diagnostic codes to identify carbon monoxide poisoning in taiwan\u2019s claims data","volume":"13","author":"Chiang","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.bj.2023.100607_bib22","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.32584","article-title":"Comparison of sodium-glucose cotransporter 2 inhibitors vs glucagonlike peptide-1 receptor Agonists and incidence of dry eye disease in patients with type 2 diabetes in taiwan","volume":"5","author":"Su","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2022.101318","article-title":"Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: a multi-institutional cohort study in Taiwan","volume":"48","author":"Shao","year":"2022","journal-title":"Diabetes Metab"},{"issue":"9","key":"10.1016\/j.bj.2023.100607_bib24","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/dom.14445","article-title":"Risk of diabetic macular oedema with sodium-glucose cotransporter-2 inhibitors in type 2 diabetes patients: a multi-institutional cohort study in Taiwan","volume":"23","author":"Su","year":"2021","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.bj.2023.100607_bib25","series-title":"Proper method for calculating average visual acuity","first-page":"388","author":"Holladay","year":"1997"},{"issue":"3","key":"10.1016\/j.bj.2023.100607_bib26","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1167\/iovs.05-0981","article-title":"Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test","volume":"47","author":"Schulze-Bonsel","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.bj.2023.100607_bib27","unstructured":"Allergan A Study of the safety and efficacy of a new treatment for diabetic macular edema. ClinicalTrials.gov identifier: NCT00168389, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00168389; 2022 [accessed 1 December 2022]."},{"key":"10.1016\/j.bj.2023.100607_bib28","unstructured":"Allergan A Study of the safety and efficacy of a new treatment for macular edema resulting from retinal vein occlusion. ClinicalTrials.gov identifier: NCT00168324, https:\/\/clinicaltrials.gov\/ct2\/show\/NCT00168324; 2022 [accessed 1 December 2022]."},{"issue":"17","key":"10.1016\/j.bj.2023.100607_bib29","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.3390\/jcm10173762","article-title":"Intravitreal dexamethasone implants for refractory macular edema in eyes with noninfectious uveitis","volume":"10","author":"Kang","year":"2021","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.bj.2023.100607_bib30","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ophtha.2019.10.005","article-title":"A collaborative retrospective study on the efficacy and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: the European DME Registry Study","volume":"127","author":"Rosenblatt","year":"2020","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-87467-6","article-title":"Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion","volume":"11","author":"Wecker","year":"2021","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.bj.2023.100607_bib32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.18240\/ijo.2021.10.15","article-title":"Dexamethasone intravitreal implant (Ozurdex) in diabetic macular edema: real-world data versus clinical trials outcomes","volume":"14","author":"Neves","year":"2021","journal-title":"Int J Ophthalmol"},{"issue":"11","key":"10.1016\/j.bj.2023.100607_bib33","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/eye.2017.111","article-title":"Identification of time point to best define \u2018sub-optimal response\u2019following intravitreal ranibizumab therapy for diabetic macular edema based on real-life data","volume":"31","author":"Chatziralli","year":"2017","journal-title":"Eye"},{"key":"10.1016\/j.bj.2023.100607_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2019.03.029","article-title":"Loss of peak vision in retinal vein occlusion patients treated for macular edema","volume":"205","author":"Iftikhar","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.bj.2023.100607_bib35","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s00417-020-04932-0","article-title":"Macular edema secondary to retinal vein occlusion in a real-life setting: a multicenter, nationwide, 3-year follow-up study","volume":"259","author":"Costa","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000492132","article-title":"Effectiveness and safety of intravitreal dexamethasone implant (Ozurdex) in patients with diabetic macular edema: a real-world experience","volume":"241","author":"Mello Filho","year":"2019","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.bj.2023.100607_bib37","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3928\/23258160-20180601-07","article-title":"Real-world assessment of dexamethasone intravitreal implant in DME: findings of the prospective, multicenter REINFORCE study","volume":"49","author":"Singer","year":"2018","journal-title":"Ophthal Surg Lasers Imag Retina"},{"issue":"11","key":"10.1016\/j.bj.2023.100607_bib38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/jamaophthalmol.2018.3848","article-title":"Correlation of central retinal thickness and visual acuity in diabetic macular edema","volume":"136","author":"De\u00e1k","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"3","key":"10.1016\/j.bj.2023.100607_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/aos.13638","article-title":"Diabetic macular oedema treated with intravitreal anti\u2010vascular endothelial growth factor\u20132\u20134 years follow\u2010up of visual acuity and retinal thickness in 566 patients following Danish national guidelines","volume":"96","author":"Hodzic\u2010Hadzibegovic","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.bj.2023.100607_bib40","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.2147\/OPTH.S264559","article-title":"Initial ten years of experience with the intravitreal dexamethasone implant: a retrospective chart review","volume":"14","author":"Wallsh","year":"2020","journal-title":"Clin Ophthalmol"},{"issue":"10","key":"10.1016\/j.bj.2023.100607_bib41","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjophthalmol-2018-312958","article-title":"Intraocular pressure change after injection of intravitreal dexamethasone (Ozurdex) implant in Korean patients","volume":"103","author":"Choi","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.bj.2023.100607_bib42","first-page":"119","article-title":"Comparison of Snellen and early treatment diabetic retinopathy study charts using a computer simulation","volume":"9","author":"Shamir","year":"2016","journal-title":"Int J Ophthalmol"},{"key":"10.1016\/j.bj.2023.100607_bib43","first-page":"311","article-title":"Prospective evaluation of visual acuity assessment: a comparison of snellen versus ETDRS charts in clinical practice (An AOS Thesis)","volume":"107","author":"Kaiser","year":"2009","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"4","key":"10.1016\/j.bj.2023.100607_bib44","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/bjophthalmol-2017-311805","article-title":"Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant","volume":"103","author":"Busch","year":"2019","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"10.1016\/j.bj.2023.100607_bib45","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/bjophthalmol-2013-303207","article-title":"Dexamethasone implants in retinal vein occlusion: 12-month clinical effectiveness using repeat injections as-needed","volume":"97","author":"Joshi","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.bj.2023.100607_bib46","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ajo.2017.10.004","article-title":"Early response to intravitreal dexamethasone implant therapy in diabetic macular edema may predict visual outcome","volume":"184","author":"Al-Khersan","year":"2017","journal-title":"Am J Ophthalmol"}],"container-title":["Biomedical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417023000446?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2319417023000446?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:14:53Z","timestamp":1762420493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2319417023000446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2319417023000446"],"URL":"https:\/\/doi.org\/10.1016\/j.bj.2023.100607","relation":{},"ISSN":["2319-4170"],"issn-type":[{"value":"2319-4170","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world effectiveness of intravitreal dexamethasone implants - Comparison between eyes eligible and ineligible for clinical trials and their associated outcomes","name":"articletitle","label":"Article Title"},{"value":"Biomedical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bj.2023.100607","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University.","name":"copyright","label":"Copyright"}],"article-number":"100607"}}